JP2024540479A - ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン - Google Patents

ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン Download PDF

Info

Publication number
JP2024540479A
JP2024540479A JP2024529329A JP2024529329A JP2024540479A JP 2024540479 A JP2024540479 A JP 2024540479A JP 2024529329 A JP2024529329 A JP 2024529329A JP 2024529329 A JP2024529329 A JP 2024529329A JP 2024540479 A JP2024540479 A JP 2024540479A
Authority
JP
Japan
Prior art keywords
vaccine
igm protease
coli
antigen
streptococcus suis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540479A5 (cg-RX-API-DMAC7.html
Inventor
ジェイコブス,アントニウス・アーノルドゥス・クリスチャン
ブロン,レムコ
Original Assignee
インターベット インターナショナル ベー. フェー.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー. フェー. filed Critical インターベット インターナショナル ベー. フェー.
Publication of JP2024540479A publication Critical patent/JP2024540479A/ja
Publication of JP2024540479A5 publication Critical patent/JP2024540479A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C12N1/066—Lysis of microorganisms by physical processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024529329A 2021-11-18 2022-11-17 ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン Pending JP2024540479A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21208911.4 2021-11-18
EP21208911 2021-11-18
PCT/EP2022/082177 WO2023088988A1 (en) 2021-11-18 2022-11-17 A method to produce a vaccine against streptococcus suis and the said vaccine

Publications (2)

Publication Number Publication Date
JP2024540479A true JP2024540479A (ja) 2024-10-31
JP2024540479A5 JP2024540479A5 (cg-RX-API-DMAC7.html) 2025-10-20

Family

ID=78695535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529329A Pending JP2024540479A (ja) 2021-11-18 2022-11-17 ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン

Country Status (5)

Country Link
US (1) US20240424077A1 (cg-RX-API-DMAC7.html)
EP (1) EP4433079A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024540479A (cg-RX-API-DMAC7.html)
CN (1) CN118265540A (cg-RX-API-DMAC7.html)
WO (1) WO2023088988A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026114933A1 (en) 2024-11-27 2026-06-04 Intervet International B.V. Stable vaccine against streptococcus suis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015181856A1 (ja) 2014-05-30 2015-12-03 株式会社アーバンマテリアルズ 弦楽器用エンドピン
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
US11155585B2 (en) 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
AU2017214441B2 (en) * 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases

Also Published As

Publication number Publication date
CN118265540A (zh) 2024-06-28
US20240424077A1 (en) 2024-12-26
EP4433079A1 (en) 2024-09-25
WO2023088988A1 (en) 2023-05-25

Similar Documents

Publication Publication Date Title
US11814415B2 (en) Vaccine against S. suis infection
KR100361562B1 (ko) 프로테이나제k에대해내성을갖는네이쎄리아메닝기티디스의표면단백질
US10039814B2 (en) Glycoconjugate vaccines
Fiske et al. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations
CN114650840A (zh) 一种针对副猪嗜血杆菌的新型疫苗
JP7812328B2 (ja) ヘモフィルス・パラスイスに対する新規ワクチン
JP2023517684A (ja) ストレプトコッカス・スイス血清型9、配列型16に対する防御のためのワクチン
CN116063548B (zh) 一种融合蛋白KP-Ag1及其用作肺炎克雷伯菌疫苗抗原的应用
US6979449B1 (en) Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis
CN107614534A (zh) 猪胸膜肺炎放线杆菌重组毒素蛋白及其应用
US7201912B2 (en) Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis
EP4433079A1 (en) A method to produce a vaccine against streptococcus suis and the said vaccine
JPH10290695A (ja) アクチノバシラス・プレウロニューモニアの弱毒化生菌
JP2024528169A (ja) 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
US20100285070A1 (en) Polynucleotides of haemophilus parasuis and its use
JP2024528172A (ja) 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
Iwanaga et al. Pili of Vibrio cholerae widely distributed in serogroup O1 strains
EP0282965B1 (en) Treponema hyodysenteriae antigen and uses therefor
RU2822516C1 (ru) Новая вакцина против haemophilus parasuis
JPWO1995034322A1 (ja) ボルデテラ属菌産生壊死毒素の精製方法およびトキソイド
WO2006113782A2 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
JPH02501732A (ja) ブタ赤痢ワクチン
RU2802072C2 (ru) Вакцина для защиты от streptococcus suis
Song et al. Expression of Clostridium perfringens alpha-epsilon soluble fusion toxin gene in Escherichia coli and its immunogenicity in mice.
US8420090B2 (en) Recombinant B. pseudomallei adhesin protein and methods and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251009

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251009